Exact Mass: 410.0841098
Exact Mass Matches: 410.0841098
Found 302 metabolites which its exact mass value is equals to given mass value 410.0841098
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nicosulfuron
C15H18N6O6S (410.10084880000005)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 129 CONFIDENCE standard compound; INTERNAL_ID 2532
BENSULFURON-METHYL
C16H18N4O7S (410.08961580000005)
spirodiclofen
Ceftibuten
Ceftibuten is only found in individuals that have used or taken this drug. It is a third-generation cephalosporin antibiotic. It is an orally-administered agent. Cefalexin is used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.Ceftibuten exerts its bactericidal action by binding to essential target proteins of the bacterial cell wall. This binding leads to inhibition of cell-wall synthesis. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Aklaviketone
A carboxylic ester that is the methyl ester of (1R,2R)-2-ethyl-2,5,7-trihydroxy-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylic acid.
MM 42842
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Tanomastat
C23H19ClO3S (410.0743374000001)
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents
JNJ-42165279
C18H17ClF2N4O3 (410.09571859999994)
D004791 - Enzyme Inhibitors JNJ-42165279 is a FAAH inhibitor that inhibits hFAAH and rFAAH with IC50 of 70±8 nM and 313 ± 28 nM respectively.
BMS-707035
C17H19FN4O5S (410.10601360000004)
D004791 - Enzyme Inhibitors > D019429 - Integrase Inhibitors > D019428 - HIV Integrase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
3-(4-Hydroxybenzoyl)epicatechin
3-(4-Hydroxybenzoyl)epicatechin is found in tea. 3-(4-Hydroxybenzoyl)epicatechin is isolated from oolong tea (Camellia sinensis var. assamica). Isolated from oolong tea (Camellia sinensis variety assamica). Epicatechin 3-p-hydroxybenzoate is found in tea.
7,11,12-Triacetoxycoumestan
Animal growth stimulan
Bms-707035
C17H19FN4O5S (410.10601360000004)
D004791 - Enzyme Inhibitors > D019429 - Integrase Inhibitors > D019428 - HIV Integrase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
Ethametsulfuron-methyl
C15H18N6O6S (410.10084880000005)
Phenobarbital N-glucoside
C18H22N2O9 (410.13252420000003)
(6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Tanomastat
C23H19ClO3S (410.0743374000001)
Aloenin
Aloenin is a glycoside. Aloenin is a natural product found in Aloe africana, Aloe nyeriensis, and other organisms with data available. See also: Aloe Vera Leaf (part of). Aloenin (Aloenin A) is a natural compound, which has potent peroxyl radical-scavenging activities and moderate inhibitory active on β-secretase (BACE)[1][2]. Aloenin (Aloenin A) is a natural compound, which has potent peroxyl radical-scavenging activities and moderate inhibitory active on β-secretase (BACE)[1][2].
Dehydropodophyllotoxin
Dehydropodophyllotoxin is a natural product found in Hernandia ovigera, Juniperus sabina, and other organisms with data available.
DIMETHYL (2Z,3Z)-2,3-BIS(BENZO[1,3]DIOXOL-5-YLMETHYLIDENE)BUTANEDIOATE
CP-544439
C18H19FN2O6S (410.09478060000004)
CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4198; ORIGINAL_PRECURSOR_SCAN_NO 4197 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4199; ORIGINAL_PRECURSOR_SCAN_NO 4198 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4224; ORIGINAL_PRECURSOR_SCAN_NO 4223 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4201; ORIGINAL_PRECURSOR_SCAN_NO 4200 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4288; ORIGINAL_PRECURSOR_SCAN_NO 4287 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4161; ORIGINAL_PRECURSOR_SCAN_NO 4159 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8355; ORIGINAL_PRECURSOR_SCAN_NO 8351 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8380; ORIGINAL_PRECURSOR_SCAN_NO 8377 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8404; ORIGINAL_PRECURSOR_SCAN_NO 8401 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8406; ORIGINAL_PRECURSOR_SCAN_NO 8401 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8384; ORIGINAL_PRECURSOR_SCAN_NO 8379 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8413; ORIGINAL_PRECURSOR_SCAN_NO 8410
3-[4-(4-Chlorobenzoyl)-1-methyl-1H-pyrrol-2-yl]-2-(phenylsulfonyl)acrylonitrile
C21H15ClN2O3S (410.0491870000001)
11-hydroxy-13-chloro-11,13-dihydroatripliciolide-8-O-tiglate
7-nor-6-oxo-2,3-dehydro-12abeta-hydroxyrotenone|7-nor-6-oxo-4,5-dehydrorotenolone
Desertorin A
A bicoumarin that is 7-hydroxy-4-methoxy-5-methyl-2H-chromen-2-one substituted by a 7-hydroxy-4-methoxy-5-methyl-2-oxo-2H-chromen-6-yl group at position 8.
Orlandin
A member of the class of 8,8-bicoumarins that is kotanin in which the methoxy groups at the 7 and 7 positions are replaced by hydroxy groups. A fungal metabolite, its isolation from Aspergillus niger was first reported in 1979.
(1R,3S,4S,5S,6S,7R,8S)-4beta-(chloromethyl)-3beta,4alpha-dihydroxy-8alpha-(3-formyl-2-methyl-propenoyloxy)-1alphaH,5alphaH,6betaH,7alphaH-guai-10(14),11(13)-dien-6,12-olide
7-hydroxy-4,5,6-trimethoxy-3,4-methylenedioxy-2,7-cycloling-7,8-diene-9,9-lactone
5-hydroxy-6,7,4-trimethoxyflavanone-5-sulfate
C18H18O9S (410.06714980000004)
9-ethyl-1,4,6,7-tetrahydroxy-10-methoxycarbonyl-7,8-dihydro-5,12-naphthacenequinone|Anhydro-epsilon-pyrromycinone
6-[4-hydroxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-4-methoxypyran-2-one
2-(hydroxymethyl)-5-(2-oxopropyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
BENSULFURON-METHYL
C16H18N4O7S (410.08961580000005)
The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.
Ala Cys Cys Asp
Ala Cys Asp Cys
Ala Cys Met Ser
C14H26N4O6S2 (410.12936959999996)
Ala Cys Ser Met
C14H26N4O6S2 (410.12936959999996)
Ala Asp Cys Cys
Ala Met Cys Ser
C14H26N4O6S2 (410.12936959999996)
Ala Met Ser Cys
C14H26N4O6S2 (410.12936959999996)
Ala Ser Cys Met
C14H26N4O6S2 (410.12936959999996)
Ala Ser Met Cys
C14H26N4O6S2 (410.12936959999996)
Cys Ala Cys Asp
Cys Ala Asp Cys
Cys Ala Met Ser
C14H26N4O6S2 (410.12936959999996)
Cys Ala Ser Met
C14H26N4O6S2 (410.12936959999996)
Cys Cys Ala Asp
Cys Cys Asp Ala
Cys Cys Glu Gly
Cys Cys Gly Glu
Cys Cys Ser Val
C14H26N4O6S2 (410.12936959999996)
Cys Cys Val Ser
C14H26N4O6S2 (410.12936959999996)
Cys Asp Ala Cys
Cys Asp Cys Ala
Cys Asp Ser Ser
Cys Glu Cys Gly
Cys Glu Gly Cys
Cys Gly Cys Glu
Cys Gly Glu Cys
Cys Gly Met Thr
C14H26N4O6S2 (410.12936959999996)
Cys Gly Thr Met
C14H26N4O6S2 (410.12936959999996)
Cys Met Ala Ser
C14H26N4O6S2 (410.12936959999996)
Cys Met Gly Thr
C14H26N4O6S2 (410.12936959999996)
Cys Met Ser Ala
C14H26N4O6S2 (410.12936959999996)
Cys Met Thr Gly
C14H26N4O6S2 (410.12936959999996)
Cys Ser Ala Met
C14H26N4O6S2 (410.12936959999996)
Cys Ser Cys Val
C14H26N4O6S2 (410.12936959999996)
Cys Ser Asp Ser
Cys Ser Met Ala
C14H26N4O6S2 (410.12936959999996)
Cys Ser Ser Asp
Cys Ser Val Cys
C14H26N4O6S2 (410.12936959999996)
Cys Thr Gly Met
C14H26N4O6S2 (410.12936959999996)
Cys Thr Met Gly
C14H26N4O6S2 (410.12936959999996)
Cys Val Cys Ser
C14H26N4O6S2 (410.12936959999996)
Cys Val Ser Cys
C14H26N4O6S2 (410.12936959999996)
Asp Ala Cys Cys
Asp Cys Ala Cys
Asp Cys Cys Ala
Asp Cys Ser Ser
cis-3-(6-Hydroxy-7-methoxy-5-benzofuranyl)acrylic acid glucuronide
Asp Ser Cys Ser
Asp Ser Ser Cys
Glu Cys Cys Gly
Glu Cys Gly Cys
Glu Gly Cys Cys
1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-hydroxy-4-oxo- glucuronide
Gly Cys Cys Glu
Gly Cys Glu Cys
Gly Cys Met Thr
C14H26N4O6S2 (410.12936959999996)
Gly Cys Thr Met
C14H26N4O6S2 (410.12936959999996)
Gly Glu Cys Cys
Gly Met Cys Thr
C14H26N4O6S2 (410.12936959999996)
Gly Met Thr Cys
C14H26N4O6S2 (410.12936959999996)
Gly Thr Cys Met
C14H26N4O6S2 (410.12936959999996)
Gly Thr Met Cys
C14H26N4O6S2 (410.12936959999996)
Met Ala Cys Ser
C14H26N4O6S2 (410.12936959999996)
Met Ala Ser Cys
C14H26N4O6S2 (410.12936959999996)
Met Cys Ala Ser
C14H26N4O6S2 (410.12936959999996)
Met Cys Gly Thr
C14H26N4O6S2 (410.12936959999996)
Met Cys Ser Ala
C14H26N4O6S2 (410.12936959999996)
Met Cys Thr Gly
C14H26N4O6S2 (410.12936959999996)
Met Gly Cys Thr
C14H26N4O6S2 (410.12936959999996)
Met Gly Thr Cys
C14H26N4O6S2 (410.12936959999996)
Met Ser Ala Cys
C14H26N4O6S2 (410.12936959999996)
Met Ser Cys Ala
C14H26N4O6S2 (410.12936959999996)
Met Thr Cys Gly
C14H26N4O6S2 (410.12936959999996)
Met Thr Gly Cys
C14H26N4O6S2 (410.12936959999996)
Ser Ala Cys Met
C14H26N4O6S2 (410.12936959999996)
Ser Ala Met Cys
C14H26N4O6S2 (410.12936959999996)
Ser Cys Ala Met
C14H26N4O6S2 (410.12936959999996)
Ser Cys Cys Val
C14H26N4O6S2 (410.12936959999996)
Ser Cys Asp Ser
Ser Cys Met Ala
C14H26N4O6S2 (410.12936959999996)
Ser Cys Ser Asp
Ser Cys Val Cys
C14H26N4O6S2 (410.12936959999996)
Ser Asp Cys Ser
Ser Asp Ser Cys
Ser Met Ala Cys
C14H26N4O6S2 (410.12936959999996)
Ser Met Cys Ala
C14H26N4O6S2 (410.12936959999996)
Ser Ser Cys Asp
Ser Ser Asp Cys
Ser Val Cys Cys
C14H26N4O6S2 (410.12936959999996)
Thr Cys Gly Met
C14H26N4O6S2 (410.12936959999996)
Thr Cys Met Gly
C14H26N4O6S2 (410.12936959999996)
Thr Gly Cys Met
C14H26N4O6S2 (410.12936959999996)
Thr Gly Met Cys
C14H26N4O6S2 (410.12936959999996)
Thr Met Cys Gly
C14H26N4O6S2 (410.12936959999996)
Thr Met Gly Cys
C14H26N4O6S2 (410.12936959999996)
Val Cys Cys Ser
C14H26N4O6S2 (410.12936959999996)
Val Cys Ser Cys
C14H26N4O6S2 (410.12936959999996)
Val Ser Cys Cys
C14H26N4O6S2 (410.12936959999996)
Nap-Ser-OH
C21H18N2O7 (410.11139579999997)
Stimol 410
3-(4-Hydroxybenzoyl)epicatechin
2,5-Diphenyl-3-(p-diphenyl)tetrazolium chloride
C25H19ClN4 (410.12981640000004)
4-Ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydro-imidazo[5,1-f][1,2,4]-triazin-2-yl)benzene-sulfonyl Chloride
C17H19ClN4O4S (410.08154840000003)
2-(4-((6-BROMO-3-NITROQUINOLIN-4-YL)AMINO)PHENYL)-2-METHYLPROPANENITRILE
Phosphonium,(3-methyl-2-buten-1-yl)triphenyl-, bromide (1:1)
(S)-tert-butyl 2-(5-(4-bromophenyl)-1h-imidazol-2-yl)pyrrolidine-1-carboxylate
N-Desmethyl Zopiclone Hydrochloride
C16H16Cl2N6O3 (410.06608859999994)
3-(1h-imidazol-4-yl)propyl(4-bromophenyl)methyl ether, maleic acid
Phosphonic acid, [[1-[[(methylsulfonyl)oxy]methyl]-2-(phenylmethoxy)ethoxy]methyl]-, diethyl ester-R
C16H27O8PS (410.11641920000005)
4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)benzene-1-sulfonyl chloride
C17H19ClN4O4S (410.08154840000003)
[4-(5-bromo-2-chloro-benzyl)-phenoxy]-tert-butyl-dimethyl-silane
benzenesulfonyl chloride;1,4-divinylbenzene;styrene
2-Propenamide-3-(2-chlorophenyl)-N-[2-[[3-(dimethylamino)propyl]thio]phenyl]-hydrochloride(1:1)
C20H23ClN2OS.ClH (410.0986314)
N-methyl ,ethyl-Morpholinium bis((trifluoromethyl)sulfonyl)imide
4-[4-(4-Chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic acid
C23H19ClO3S (410.0743374000001)
2-[[5-(2-furanyl)-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]-N-(2-methoxyphenyl)acetamide
2-[[2-methyl-5-nitro-3-(phenylmethyl)-4-imidazolyl]thio]-6-nitro-1H-benzimidazole
C18H14N6O4S (410.07972040000004)
2H-Pyran-4-carboxamide, 4-(((4-(4-fluorophenoxy)phenyl)sulfonyl)amino)tetrahydro-N-hydroxy-
C18H19FN2O6S (410.09478060000004)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors
4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid
(S)-1-[2-Deoxy-3,5-O-(1-phosphono)benzylidene-B-D-threo-pentofuranosyl]thymine
C17H19N2O8P (410.08789840000003)
Diclofenac Epolamine
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
4-[[[3-(6-Methoxypyridin-3-yl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]benzenesulfonamide
5-Ethyl-5-phenyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3-diazinane-2,4,6-trione
C18H22N2O9 (410.13252420000003)
1-(2-Hydroxyethyl)pyrrolidinium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
ethyl 2-chloro-5-[5-[(E)-(5-cyano-4-methyl-2,6-dioxopyridin-3-ylidene)methyl]furan-2-yl]benzoate
C21H15ClN2O5 (410.06694500000003)
1-(4-aminofurazan-3-yl)-N-[1-(3-hydroxyphenyl)ethylideneamino]-5-(2-thienyl)triazole-4-carboxamide
4-{[(E)-(3-bromo-4-hydroxy-5-methoxyphenyl)methylidene]amino}-5-cyclohexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione
N-[3-(dimethylamino)propyl]-N-(6-methyl-1,3-benzothiazol-2-yl)-1,3-benzothiazole-6-carboxamide
N-[3-(4-methyl-1-piperidinyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide
C22H22N2O4S (410.13002120000004)
5-O-phosphono-2-deoxyribosyl-(3->5)-2-deoxyribose
A 2-deoxyribose bisphosphate that is 2-deoxy-alpha-D-ribofuranose 3,5-bisphosphate in which the phosphate group at position 3 is esterfied by a 2-deoxy-alpha-D-ribofuranos-5-yl group.
2-Deoxy-5-(4,5-dihydroxypentyl)uridine 5-monophosphate
A pyrimidine 2-deoxyribonucleoside 5-monophosphate having 5-(4,5-dihydroxypentyl)uracil as the nucleobase.
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-[[3-(phenylmethyl)-2-imidazo[4,5-b]pyridinyl]thio]acetamide
6-[3-(cyclopropylmethoxy)-4-methoxyphenyl]-3-(2-fluorophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
(1R,5S)-3-(2-fluorophenyl)sulfonyl-7-[4-(5-pyrimidinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
[2-[(E)-(2-Amino-4-oxo-1,3-thiazol-5-ylidene)methyl]phenyl] naphthalene-2-sulfonate
3,4,5-Trihydroxy-6-[3-(4-methoxy-1-benzouran-5-yl)-3-oxopropanoyl]oxyoxane-2-carboxylic acid
6-[1-Carboxy-2-(4-methoxy-1-benzofuran-5-yl)-2-oxoethyl]-3,4,5-trihydroxyoxane-2-carboxylic acid
[2-Hydroxy-2-[6-(2-methylbut-3-en-2-yl)-7-oxo-2,3-dihydrouro[3,2-g]chromen-2-yl]propyl] hydrogen sulate
2-(hydroxymethyl)-5-(2-oxopropyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Ceftibuten
A third-generation cephalosporin antibiotic with a [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino substituent at the 7 position of the cephem skeleton. An orally-administered agent, ceftibuten is used as the dihydrate to treat urinary-tract and respiratory-tract infections. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
IEM-1754
IEM-1754, a dicationic adamantane derivative, is a potent blocker of open channels of native ionotropic glutamate receptors including quisqualate-sensitive receptors in insect muscles, NMDAR in cultured rat cortical neurons, and AMPAR in freshly isolated hippocampal cells. IEM-1754 shows anticonvulsant potency in vivo[1][2].
LUF6000
LUF6000 is an orally active allosteric modulator of the A3 adenosine receptor. LUF6000 has potent anti-inflammatory effect[1][2].
SIRT2/6-IN-1
C19H14N4O5S (410.06848740000004)
SIRT2/6-IN-1 (Compound 5) is a SIRT6/SIRT2 inhibitor, with IC50s of 106 μM and 114 μM. SIRT2/6-IN-1 increases H3K9 acetylation, increases glucose uptake and reduces TNF-α secretion in cells[1].
4,17,19-trihydroxy-11-methyl-2,13-dioxo-12-oxa-6-thiatricyclo[13.4.0.0³,⁷]nonadeca-1(19),15,17-triene-4-carboxylic acid
(11s,12r,15s,16s)-4,11,14-trihydroxy-15-(4-hydroxyphenyl)-13-oxa-2,9-diazatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1,3,5,7,9-pentaene-14-carboxylic acid
C21H18N2O7 (410.11139579999997)
11,11-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),2(6),7-triene-5,13-dione
9-(2h-1,3-benzodioxol-5-yl)-5-hydroxy-4,6,8-trimethoxy-3h-naphtho[2,3-c]furan-1-one
9-(2h-1,3-benzodioxol-5-yl)-5-hydroxy-4,6,7-trimethoxy-3h-naphtho[2,3-c]furan-1-one
methyl 2-ethyl-4,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydrotetracene-1-carboxylate
(3s)-1,7-bis(3,4-dihydroxyphenyl)-5-oxoheptane-3-sulfonic acid
(3s)-9-(2h-1,3-benzodioxol-5-yl)-4-hydroxy-3,6,7-trimethoxy-3h-naphtho[2,3-c]furan-1-one
(6r)-8,9-dihydroxy-3-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
(4s,8s,10s)-2,12-dihydroxy-16-[(1s)-1-hydroxyethyl]-10-methyl-5,9-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1,3(11),12,15(20),16,18-hexaene-6,14,21-trione
2,12-dihydroxy-16-(1-hydroxyethyl)-10-methyl-5,9-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1,3(11),12,15(20),16,18-hexaene-6,14,21-trione
6,7,12,16,17-pentahydroxy-12-(2-oxopropyl)-3,20-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(13),2(10),4,6,8,14,16,18-octaen-11-one
methyl 3-chloro-2-[2,4-dimethoxy-6-(methoxycarbonyl)phenoxy]-6-hydroxy-4-methylbenzoate
(1s,13s,21r)-16,17-dimethoxy-12-oxo-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,5,8,10,14(19),15,17-heptaen-21-yl acetate
(2z,4s,7r,8r,9r,11r)-7-(chloromethyl)-7-hydroxy-2,11-dimethyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-1(13),2-dien-9-yl (2z)-2-methylbut-2-enoate
2-(acetyloxy)-4',5,6-trihydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl acetate
(2s,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one
6-(4-hydroxy-2-methyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4-methoxypyran-2-one
6-(4-hydroxy-2-methyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4-methoxypyran-2-one
2-[(3-hydroxy-1,4-dioxonaphthalen-2-yl)oxy]-3-methylanthracene-9,10-dione
2-bromo-5-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]phenazin-1-one
(3ar,4s,6ar,8s,9s,9as,9bs)-9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl (2e)-2-methyl-4-oxobut-2-enoate
(2r)-2,4-dihydroxy-4-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]-5-methoxy-5-oxopentanoic acid
C18H18O9S (410.06714980000004)
8,9-dihydroxy-3-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
4-(6-hydroxy-2h-1,3-benzodioxol-5-yl)-6,7,9-trimethoxy-3h-naphtho[2,3-c]furan-1-one
4,7-dihydroxy-4',7'-dimethoxy-5,5'-dimethyl-[3,3'-bichromene]-2,2'-dione
6-(4-hydroxy-2-methyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4-methoxypyran-2-one
7-chloro-6,10,14,19-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1(19),3,5,7,10,13,15,17-octaene-2,12-dione
7-(chloromethyl)-7-hydroxy-2,11-dimethyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-1(13),2-dien-9-yl 2-methylbut-2-enoate
methyl (4r)-2-ethyl-4,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydrotetracene-1-carboxylate
2,4-dihydroxy-4-{5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl}-5-methoxy-5-oxopentanoic acid
C18H18O9S (410.06714980000004)
(2z,4s,7r,8r,9r,11r)-7-(chloromethyl)-7-hydroxy-2,11-dimethyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-1(13),2-dien-9-yl (2e)-2-methylbut-2-enoate
7,7'-dihydroxy-4,4'-dimethoxy-5,5'-dimethyl-[6,8'-bichromene]-2,2'-dione
6-(acetyloxy)-2,4',5-trihydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl acetate
9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl 2-methyl-4-oxobut-2-enoate
(3r,4s,7r,11s)-4,17,19-trihydroxy-11-methyl-2,13-dioxo-12-oxa-6-thiatricyclo[13.4.0.0³,⁷]nonadeca-1(19),15,17-triene-4-carboxylic acid
1,4-dimethyl (2z,3z)-2,3-bis(2h-1,3-benzodioxol-4-ylmethylidene)butanedioate
1,7-bis(3,4-dihydroxyphenyl)-5-oxoheptane-3-sulfonic acid
16,17-dimethoxy-12-oxo-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,5,8,10,14(19),15,17-heptaen-21-yl acetate
6-(4-hydroxy-2-methyl-6-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4-methoxypyran-2-one
methyl (1s,4s,8r,10s,11e,14s)-11-{[4-(acetyloxy)phenyl]methylidene}-12-oxo-7,9,13-trioxatetracyclo[6.5.1.0¹,¹⁰.0⁴,¹⁴]tetradeca-2,5-diene-5-carboxylate
4,11,14-trihydroxy-15-(4-hydroxyphenyl)-13-oxa-2,9-diazatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1,3,5,7,9-pentaene-14-carboxylic acid
C21H18N2O7 (410.11139579999997)
11,11-dimethyl-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),2(6),7-triene-5,13-dione
6,6',7,7'-tetramethoxy-[3,3'-bichromene]-2,2'-dione
8,9-dihydroxy-3-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
(2s,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one
7,7'-dihydroxy-4,4'-dimethoxy-5,5'-dimethyl-[6,6'-bichromene]-2,2'-dione
{5-hydroxy-6,10-dimethoxy-4-oxo-2-propylbenzo[h]chromen-8-yl}oxidanesulfonic acid
C18H18O9S (410.06714980000004)
(2r,4s)-2,4-dihydroxy-4-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]-5-methoxy-5-oxopentanoic acid
C18H18O9S (410.06714980000004)